Highlights on US FDA-approved fluorinated drugs over the past five years (2018–2022)

S Ali, J Zhou - European journal of medicinal chemistry, 2023 - Elsevier
The objective of this review is to provide an update on the fluorine-containing drugs
approved by US Food and Drug Administration in the span of past five years (2018–2022) …

Development of 18F-Labeled Acridone Analogue for Tumor Imaging via Stimulator of Interferon Genes Targeting

H Liu, Y Sun, J Li, Y Chen, J Liu, J Fang… - Molecular …, 2023 - ACS Publications
The stimulator of interferon genes (STING) is a pivotal protein in the production of STING-
dependent type I interferon, which has the potential to enhance tumor rejection. The …

MicroPET Imaging of Riboflavin Transporter 3 Expression in Myocardial Infarction/Reperfusion Rat Models with Radiofluorinated Riboflavin

J Li, X Hong, Y Chen, B Yin, H Yang, C Shi… - ACS Pharmacology & …, 2024 - ACS Publications
Riboflavin transporter 3 (RFVT3) represents a potential cardioprotective biotarget in
energetic metabolism reprogramming after myocardial infarction/reperfusion (MI/R). This …

Development of radiotracers for riboflavin transporter 3 imaging in diseases—A brief overview

J Li, X Zhang - Journal of Labelled Compounds and …, 2024 - Wiley Online Library
Riboflavin (RF, vitamin B2) plays a key role in metabolic oxidation–reduction reactions,
especially in the mitochondrial reprogramming of energy metabolism. Riboflavin transporter …

[PDF][PDF] Targeting Riboflavin Receptor 3 in Neurological Diseases

J Li, X Zhang, K Chen - Neurodegener Dis Current …, 2022 - neurodegenerativejournal.com
Neurological diseases are widespread and serious global illnesses. Neurons highly rely on
aerobic metabolism in mitochondria. Riboflavin receptor 3 (RFVT3) is a vital section of the …